pI: 7.4569 |
Length (AA): 328 |
MW (Da): 37184 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_129189)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G16970 | protein kinase superfamily protein |
Brugia malayi | Bm1_05720 | Protein kinase domain containing protein |
Candida albicans | CaO19.11045 | protein serine/threonine kinase |
Candida albicans | CaO19.3561 | protein serine/threonine kinase |
Caenorhabditis elegans | CELE_C34G6.5 | Protein CDC-7 |
Dictyostelium discoideum | DDB_G0292152 | CDC7 family protein kinase |
Dictyostelium discoideum | DDB_G0270756 | GATA zinc finger domain-containing protein 7 |
Drosophila melanogaster | Dmel_CG5790 | CG5790 gene product from transcript CG5790-RB |
Drosophila melanogaster | Dmel_CG32742 | lethal (1) G0148 |
Echinococcus granulosus | EgrG_000953500 | CDC7 cell division cycle 7 |
Echinococcus multilocularis | EmuJ_000953500 | CDC7 cell division cycle 7 |
Giardia lamblia | GL50803_112076 | Kinase, CDC7 |
Homo sapiens | ENSG00000097046 | cell division cycle 7 |
Loa Loa (eye worm) | LOAG_03017 | CDC7 protein kinase |
Mus musculus | ENSMUSG00000029283 | cell division cycle 7 (S. cerevisiae) |
Oryza sativa | 4349401 | Os10g0563500 |
Onchocerca volvulus | OVOC1780 |
|
Onchocerca volvulus | OVOC3268 |
|
Saccharomyces cerevisiae | YDL017W | Cdc7p |
Schistosoma japonicum | Sjp_0111110 | ko:K02214 cell division control protein CDC7, putative |
Schistosoma mansoni | Smp_177120 | serine/threonine protein kinase |
Schmidtea mediterranea | mk4.000196.02 | Cdc7-like protein |
Trichomonas vaginalis | TVAG_202140 | CMGC family protein kinase |
Trichomonas vaginalis | TVAG_199490 | CMGC family protein kinase |
Trichomonas vaginalis | TVAG_373340 | CMGC family protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
YDL017W | Saccharomyces cerevisiae | inviable | yeastgenome |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | cell division cycle 7 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 27.8% | 198 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 25.9% | 317 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 26.0% | 327 aa | Compounds | References |
Plasmodium falciparum | MO15-related protein kinase | 324 aa | 25.0% | 332 aa | Compounds | References |
Plasmodium falciparum | protein kinase 6 | 305 aa | 27.2% | 334 aa | Compounds | References |
Leishmania major | cell division related protein kinase 2,cdc2-related kinase | 311 aa | 27.4% | 318 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 28.1% | 320 aa | Compounds | References |
Plasmodium falciparum | protein kinase 5 | 288 aa | 28.1% | 320 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 25.5% | 326 aa | Compounds | References |
Trypanosoma cruzi | cAMP-dependent protein kinase catalytic subunit 3 | 200 aa | 30.2% | 162 aa | Compounds | References |